Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene
- PMID: 2184192
Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene
Abstract
The proliferative response of T cells is known to decrease with age of the T cell donor. We now report that this proliferative defect affects both major subsets (CD4+, CD8- and CD4-, CD8+) of peripheral T cells from old humans. Furthermore, this proliferative defect can be detected within the first hours after addition of mitogen by a reduction in the steady state levels of c-myc mRNA in T cell cultures from old donors. Lymphocytes from old humans cultured with PHA have less than 50% of the level of c-myc message than do such cultures from young donors. Nuclear run-on assays suggest that the decreased steady state level of c-myc mRNA in cultures from old donors is caused by reduced transcription of the c-myc gene in T cells from old donors. The age-associated defect in transcription of the c-myc gene affects the second exon to a greater extent than the first, noncoding exon. Individual T lymphocytes from old donors that do express c-myc message, detected by in situ hybridization, have the same intracellular level of c-myc message as T lymphocytes from young donors. These data add additional support for the hypothesis that the proliferative defect of T lymphocytes from old humans is caused by the smaller fraction of T cells from old as compared with young humans that can be activated by mitogens to enter the G1 phase of the cell cycle.
Similar articles
-
Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.J Immunol. 1988 Apr 1;140(7):2442-6. J Immunol. 1988. PMID: 3280682
-
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.Nature. 1987 Jul 30-Aug 5;328(6129):445-9. doi: 10.1038/328445a0. Nature. 1987. PMID: 3302722
-
Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.J Immunol. 1988 Sep 15;141(6):2145-52. J Immunol. 1988. PMID: 3139753
-
The response of human lymphocytes to phytohemagglutinin is impaired at different levels during aging.Ann N Y Acad Sci. 1992 Dec 26;673:110-9. doi: 10.1111/j.1749-6632.1992.tb27442.x. Ann N Y Acad Sci. 1992. PMID: 1485708 Review.
-
Normal and cancer cell metabolism: lymphocytes and lymphoma.FEBS J. 2012 Aug;279(15):2598-609. doi: 10.1111/j.1742-4658.2012.08651.x. Epub 2012 Jul 3. FEBS J. 2012. PMID: 22672505 Review.
Cited by
-
Transcriptomic analysis of human IL-7 receptor alpha low and high effector memory CD8+ T cells reveals an age-associated signature linked to influenza vaccine response in older adults.Aging Cell. 2019 Aug;18(4):e12960. doi: 10.1111/acel.12960. Epub 2019 May 1. Aging Cell. 2019. PMID: 31044512 Free PMC article.
-
Cell proliferation and apoptosis in the immune system in the elderly.Immunol Res. 2000;21(1):31-8. doi: 10.1385/IR:21:1:31. Immunol Res. 2000. PMID: 10803881 Review.
-
Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation.Clin Exp Med. 2015 May;15(2):189-203. doi: 10.1007/s10238-014-0285-6. Epub 2014 Aug 7. Clin Exp Med. 2015. PMID: 25099175
-
Intracellular free Ca2+ fluxes and responses to phorbol ester in T lymphocytes from healthy elderly subjects.Clin Exp Immunol. 1992 Jul;89(1):158-63. doi: 10.1111/j.1365-2249.1992.tb06896.x. Clin Exp Immunol. 1992. PMID: 1385766 Free PMC article.
-
Theoretical and in silico Analyses Reveal MYC as a Dynamic Network Biomarker in Colon and Rectal Cancer.Front Genet. 2020 Oct 20;11:555540. doi: 10.3389/fgene.2020.555540. eCollection 2020. Front Genet. 2020. PMID: 33193630 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials